Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02805504 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures
A Phase 4 study, sponsored by Loma Linda University.
- Completed
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
NCT02805504: Completed Phase 4 study, sponsored by Loma Linda University.
NCT02805504 is a Phase 4 study that has completed, run by Loma Linda University. The registered enrollment target is 136 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02805504, a Phase 4 study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
Study Summary
A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.
Primary Outcome
Postoperative analgesic use will be measured in oral morphine equivalents dose given to patients in the first three days postoperatively
Interventions
- DRUG Exparel
- DRUG Marcaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2016-07-11 |
| Est. Completion | 2022-05-09 |
| Phase | Phase 4 |
What the finished NCT02805504 record still lists
NCT02805504 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT02805504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02805504 about?
NCT02805504 is a clinical study titled "Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures". A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.
What is the current status of trial NCT02805504?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2016-07-11. Estimated completion is 2022-05-09.
What interventions are being tested in trial NCT02805504?
The interventions under investigation include: Exparel (DRUG), Marcaine (DRUG).
Who is sponsoring clinical trial NCT02805504?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02805504's enrollment target sits among peer trials
136 596th of 2000 higher than 1,400 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI